Moreover, SRSF1 mediates the oncogenic splicing of RBBP6, favoring the RBBP6-1 isoform over the tumor-suppressive RBBP6-3, with knockdown restoring p53 expression and impairing MM cell growth [187]. This evidence concerns the gene TP53 and Miyoshi myopathy.